CollPlant Biotechnologies

CLGN • NASDAQ • Stock Fundamentals

CollPlant Biotechnologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yehiel Tal, with a market cap of $6.0M.

Market Cap$6.0M

Employees73.0

CEOYehiel Tal

CountryIsrael

Healthcare

Biotechnology

Most Recent EarningsMar 26, 2026 · 2 months 2 days agoQ4 2025

Next EarningsAug 20, 2026 · in 3 monthsBefore Market Open · Q2 2026

Financials

Based on Q4 2025 filing

Common questions about CollPlant Biotechnologies

CollPlant Biotechnologies (CLGN) has a market capitalization of $6.0M and trades on NASDAQ.

CollPlant Biotechnologies has approximately 73 employees.